Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How do you image when using DIBH with breast treatment?
Do you use portal or orthogonal imaging or both?
Answer from: Radiation Oncologist at Academic Institution
For patients undergoing DIBH we use standard portal imaging only.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
VisionRT/OSMS daily with weekly standard ports
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
We use daily imaging of one tangential field . To minimize dose and exposure we only take one image of actual field and not double exposure with open field
Sign in or Register to read more
5160
5179
5178
Related Questions
Have you seen any increased dermatologic toxicity with whole breast or chest wall radiation if patients have received recent or concurrent pembrolizumab?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
When utilizing hypofractionated radiotherapy in the post mastectomy setting, are the nodal regions dose painted to a different dose or the same dose as the chest wall/reconstructed breast?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
In the setting of recurrent breast cancer localized to the chest wall (no prior RT), do you allow concurrent abemaciclib or Enhertu with post-operative comprehensive chest wall irradiation?
How would you manage a patient with micrometastatic node positive tumor post mastectomy (no neoadjuvant chemotherapy)?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
In patients with history of prior axillary surgery, subsequently with breast cancer recurrence, and sentinel lymph nodes mapped to internal mammary area (but were not biopsied), do you offer post-mastectomy radiation to cover the IMNs?
In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision?
Can the SIB regimen from RTOG 1005 be extrapolated to all patients requiring whole breast irradiation?